Latest Articles
KRA to monitor mobile phones in tax compliance bid - The Standard
KRA to monitor mobile phones in tax compliance bid The Standard
Published: Oct. 24, 2024, 5:55 p.m.
Pembrolizumab Earns EU Approval in 2 New Indications for Endometrial and Cervical Cancer - OncLive
Pembrolizumab Earns EU Approval in 2 New Indications for Endometrial and Cervical Cancer OncLive
Published: Oct. 24, 2024, 3:55 p.m.
Pharmacokinetic Relationship Between GLP-1s, Endometrial Cancer Cell Growth - DocWire News
Pharmacokinetic Relationship Between GLP-1s, Endometrial Cancer Cell Growth DocWire News
Published: Oct. 24, 2024, 2:55 p.m.
Ending the hurt - Yale Alumni Magazine
Ending the hurt Yale Alumni Magazine
Published: Oct. 24, 2024, 2:34 p.m.
Bayer, Dewpoint to work on heart drug; Viking’s obesity manufacturing plans - Endpoints News
Bayer, Dewpoint to work on heart drug; Viking’s obesity manufacturing plans Endpoints News
Published: Oct. 24, 2024, 2:27 p.m.
Execution of Kenyan in Saudi Arabia postponed by one year - The Standard
Execution of Kenyan in Saudi Arabia postponed by one year The Standard
Published: Oct. 24, 2024, 2:22 p.m.
Episode 6: The Evolving Role of Radiation Therapy in Endometrial Cancer - Medscape
Episode 6: The Evolving Role of Radiation Therapy in Endometrial Cancer Medscape
Published: Oct. 24, 2024, 1:44 p.m.
Senator Hezena is officially off the market - The Standard
Senator Hezena is officially off the market The Standard
Published: Oct. 24, 2024, 11:54 a.m.
Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers - BioSpace
Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers BioSpace
Published: Oct. 24, 2024, 11:46 a.m.
Shock Diagnosis: Woman Discovers She’s Got Multiple Private Parts - MSN
Shock Diagnosis: Woman Discovers She’s Got Multiple Private Parts MSN
Published: Oct. 24, 2024, 11:16 a.m.
Link copied to clipboard!